Last reviewed · How we verify

NCT03324204

Shock Wave Therapy Versus Neuromuscular Training in Women With Patellofemoral Pain

Status unknown NA Last updated 27 October 2017
What this trial tests

NA trial testing Neuromuscular Training in Patellofemoral Pain Syndrome in 100 participants. Status unknown.

Timeline
1 August 2014
Primary endpoint
1 June 2018
1 January 2019

Quick facts

Lead sponsorMedical University of Silesia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date1 August 2014
Primary completion1 June 2018
Estimated completion1 January 2019
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Silesia

Who can join

Adults 18 to 30, female only, with Patellofemoral Pain Syndrome or Knee Pain Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the trial is to compare the efficacy of extracorporeal shock wave therapy (ESWT) versus neuromuscular training (TR) in reducing pain in women with patellofemoral pain (PFP). Women with PFP will be randomly divided into two therapeutic groups: ESWT and TR. The ESWT group will undergo extracorporeal shock wave therapy to the iliotibial band and tensor fascia latae. The TR group will be treated with neuromuscular training. The women's gait will be analysed and the strength of hip abductors and internal rotators will be measured. Additionally, the women's pain and health status will be assessed with the visual analogue scale and the Lysholm Scale. Outcomes will be registered at baseline, and then at five weeks and at three months post-therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Neuromuscular Training

Trials testing the same drug.

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

Other Medical University of Silesia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03324204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing